Comparative Pharmacology
Head-to-head clinical analysis: PHISO SCRUB versus READYPREP CHG.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PHISO SCRUB versus READYPREP CHG.
PHISO-SCRUB vs READYPREP CHG
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Phiso-Scrub is a topical antiseptic containing triclosan, which inhibits bacterial fatty acid synthesis by targeting enoyl-acyl carrier protein reductase (FabI), leading to disruption of cell membrane integrity and bacterial cell death.
Chlorhexidine gluconate disrupts microbial cell membranes, causing leakage of cytoplasmic contents and cell death. Its cationic nature binds to negatively charged bacterial cell walls, providing persistent antimicrobial activity.
Topical application to affected area once daily; chlorhexidine gluconate 4% scrub, lather for 3-5 minutes, rinse thoroughly.
No standard systemic dosing; used as a 4% chlorhexidine gluconate topical antiseptic solution applied once daily to entire body for preoperative skin preparation or for chlorhexidine bathing in infection prevention protocols.
None Documented
None Documented
Approximately 8-12 hours in patients with normal renal function (CrCl >90 mL/min). Half-life is significantly prolonged in renal impairment (up to 40 hours in ESRD).
60 minutes (terminal) in patients with normal renal function; prolonged in renal impairment.
Primarily renal excretion of unchanged drug (approximately 70-80% of absorbed dose). Biliary/fecal elimination accounts for the remainder (20-30%).
Renal: ~100% unchanged via glomerular filtration. No biliary or fecal elimination.
Category C
Category C
Antiseptic
Antiseptic